Citadel Advisors’s Climb Bio, Inc. Common Stock CLYM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $172K | Buy |
138,392
+55,638
| +67% | +$69K | ﹤0.01% | 5064 |
|
|
2025
Q1 | $101K | Buy |
82,754
+16,282
| +24% | +$19.9K | ﹤0.01% | 5154 |
|
|
2024
Q4 | $120K | Buy |
+66,472
| New | +$120K | ﹤0.01% | 5101 |
|
|
2022
Q4 | – | Sell |
-11,587
| Closed | -$37K | – | 6829 |
|
|
2022
Q3 | $37K | Sell |
11,587
-3,624
| -24% | -$11.6K | ﹤0.01% | 5403 |
|
|
2022
Q2 | $46K | Buy |
+15,211
| New | +$46K | ﹤0.01% | 5531 |
|